首页> 外文期刊>Journal of Advanced Pharmaceutical Technology Research >Development and evaluation of aceclofenac-loaded mucoadhesive microcapsules
【24h】

Development and evaluation of aceclofenac-loaded mucoadhesive microcapsules

机译:醋氯芬酸粘膜粘附微胶囊的开发与评价

获取原文
           

摘要

Microencapsulation is an accepted process used to achieve controlled release and drug targeting for many years. Mucoadhesion has been a topic of interest in the design of drug delivery systems to prolong its intestinal residence time. Mucoadhesion facilitates the intimate contact of the dosage form with the underlying absorption surface for improved bioavailability of drugs. Aceclofenac is a newer nonsteroidal anti-inflammatory drug (NSAID) having short biological half-life of 4–4.3 h, and therefore a sustained release medication is required to get prolonged effect and to reduce fluctuations in drug plasma concentration levels. Aceclofenac microcapsules were prepared employing sodium alginate as the coat material in combination with some mucoadhesive polymers such as (hydroxypropyl methyl cellulose) HPMC, (sodium carboxymethyl cellulose) Sod. CMC, Carbopol and methyl cellulose (MC) (drug:SA:polymer at ratios 2:2:1, 2:3:1 and 2:4:1), following orifice-ionic gelation technique. Infrared (IR) spectroscopy, differential scanning calorimetry and X-ray diffraction studies proved the compositions were compatible, without any interaction between the drug and excipients. The prepared microcapsules were evaluated for various physical and release parameters. The resulted microcapsules were found to be discrete and spherical in scanning electron microscopy studies and free flowing in rheological studies. The size of microcapsules was found to be around 757.44 ± 5.201 μm to 814.46 ± 6.586 μm. The microencapsulation efficiency was found to be higher in HPMC than in Carbopol > MC > Sod. CMC containing formulations, but the swelling index was found to be higher in Sod. CMC formulations. The microcapsules with HPMC exhibited good mucoadhesive property in the in vitro wash-off test. In vitro drug release studies of aceclofenac microcapsules were carried out up to 24 h and they followed zero-order release kinetics with Super Case II mechanism. The drug release from the microcapsules was sustained over a prolonged period with greater retardation in drug:SA:HPMC (2:4:1) containing microcapsules and this proved to be the best formulation.Keywords: Aceclofenac, controlled release, ionic-orifice gelation, microencapsulation, mucoadhesion
机译:微囊化是用于实现控释和靶向药物多年的公认方法。粘膜粘连一直是延长药物在肠道中停留时间的设计方法。粘膜粘着促进剂型与下面的吸收表面紧密接触,以改善药物的生物利用度。醋氯芬酸是一种较新的非甾体类抗炎药(NSAID),其生物半衰期较短,为4–4.3小时,因此需要持续释放的药物以延长疗效并减少血浆血浆浓度水平的波动。醋氯芬酸微胶囊是用藻酸钠作为包衣材料与一些粘膜粘附性聚合物(如(羟丙基甲基纤维素)HPMC,(羧甲基纤维素钠)Sod)结合制成的。 CMC,Carbopol和甲基纤维素(MC)(药物:SA:聚合物的比例为2:2:1、2:3:1和2:4:1),采用孔离子凝胶技术。红外(IR)光谱,差示扫描量热法和X射线衍射研究证明了该组合物是相容的,药物与赋形剂之间没有任何相互作用。评价制备的微胶囊的各种物理和释放参数。在扫描电子显微镜研究中发现所得的微囊是离散的和球形的,在流变学研究中发现其为自由流动的。发现微胶囊的尺寸为约757.44±5.201μm至814.46±6.586μm。发现HPMC中的微囊包封效率高于Carbopol> MC> Sod。含有CMC的配方,但在Sod中发现溶胀指数较高。 CMC配方。具有HPMC的微胶囊在体外冲洗试验中表现出良好的粘膜粘附特性​​。醋氯芬酸微胶囊的体外药物释放研究进行了长达24小时,并且它们遵循Super Case II机制的零级释放动力学。微囊中的药物释放可以持续较长时间,并且含微囊的药物:SA:HPMC(2:4:1)的阻滞作用更大,这被证明是最好的制剂。关键词:醋氯芬酸,控释,离子孔凝胶,微囊化,粘膜粘附

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号